Literature DB >> 17960689

Social and economic impact of inflammatory arthritis.

Martin Jan Bergman1.   

Abstract

The inflammatory arthritides place a substantial burden on society with direct healthcare costs and indirect costs due to reduced productivity and social function. These progressive conditions cause significant pain, joint destruction, and reduced function, and therefore also place a substantial disease burden on affected patients and their families. This article reviews the epidemiology, social impact, and disease costs associated with 3 common inflammatory arthritides--rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis.

Entities:  

Mesh:

Year:  2006        PMID: 17960689

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  9 in total

Review 1.  Peri-articular lymphatic system and "Bi" theory of Chinese medicine in the pathogenesis and treatment of arthritis.

Authors:  Qian-Qian Liang; Qi Shi; Ronald W Wood; Lian-Ping Xing; Yong-Jun Wang
Journal:  Chin J Integr Med       Date:  2015-10-03       Impact factor: 1.978

2.  Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire.

Authors:  Patrick Lee Dominguez; M Elaine Husni; Elizabeth W Holt; Stephanie Tyler; Abrar A Qureshi
Journal:  Arch Dermatol Res       Date:  2009-07-15       Impact factor: 3.017

3.  Use of a whole-slide imaging system to assess the presence and alteration of lymphatic vessels in joint sections of arthritic mice.

Authors:  J X Shi; Q Q Liang; Y J Wang; R A Mooney; B F Boyce; L Xing
Journal:  Biotech Histochem       Date:  2012-11-23       Impact factor: 1.718

Review 4.  Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondylarthritis) and gastrointestinal or liver comorbidity.

Authors:  Helga Radner; Sofia Ramiro; Rachelle Buchbinder; Robert B M Landewé; Désirée van der Heijde; Daniel Aletaha
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18

5.  Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative.

Authors:  Samuel L Whittle; Alexandra N Colebatch; Rachelle Buchbinder; Christopher J Edwards; Karen Adams; Matthias Englbrecht; Glen Hazlewood; Jonathan L Marks; Helga Radner; Sofia Ramiro; Bethan L Richards; Ingo H Tarner; Daniel Aletaha; Claire Bombardier; Robert B Landewé; Ulf Müller-Ladner; Johannes W J Bijlsma; Jaime C Branco; Vivian P Bykerk; Geraldo da Rocha Castelar Pinheiro; Anca I Catrina; Pekka Hannonen; Patrick Kiely; Burkhard Leeb; Elisabeth Lie; Píndaro Martinez-Osuna; Carlomaurizio Montecucco; Mikkel Ostergaard; Rene Westhovens; Jane Zochling; Désirée van der Heijde
Journal:  Rheumatology (Oxford)       Date:  2012-03-24       Impact factor: 7.580

6.  Use of steroid and nonsteroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review protocol.

Authors:  Mariana Del Grossi Moura; Luciane Cruz Lopes; Marcus Tolentino Silva; Sílvio Barberato-Filho; Rogério Heládio Lopes Motta; Cristiane de Cássia Bergamaschi
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

7.  Neuropathic Pain: Unexplored and Significant Relationship With Psoriatic Arthritis and Functional Parameters.

Authors:  Çağrı Ünal Ulutatar; Fırat Ulutatar; Mehmet Tuncay DuruÖz
Journal:  Arch Rheumatol       Date:  2019-12-17       Impact factor: 1.472

8.  Oral phosphatidylcholine pretreatment alleviates the signs of experimental rheumatoid arthritis.

Authors:  Gabor Eros; Saleh Ibrahim; Nikolai Siebert; Mihály Boros; Brigitte Vollmar
Journal:  Arthritis Res Ther       Date:  2009-03-18       Impact factor: 5.156

9.  High frequency of fibromyalgia in patients with psoriatic arthritis: a pilot study.

Authors:  Marina N Magrey; Maria Antonelli; Neena James; Muhammad Asim Khan
Journal:  Arthritis       Date:  2013-02-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.